Email Updates

You are here

Home

13 NOVEMBER 2020 VOLUME 22 ISSUE 44

Media Coverage

  • Escalate HIV Adherence Strategies Amid COVID-19

    "The writing is on the wall" that virtual care is not meeting the needs of people with HIV who struggled with viral suppression even before the COVID-19 pandemic, said Jason Farley, PhD, ANP-BC, AACRN, associate professor of nursing at Johns Hopkins University, Baltimore, Maryland. So it's time for HIV care teams, especially clinics in the Ryan White HIV/AIDS Program, to get creative in bringing wraparound services to patients.

    November 12, 2020
    Treatment
    Medscape

  • The Latest Advancement in HIV Treatment Proves How Important It Is To Include Women in Clinical Trials Research

    This week marked an important milestone in HIV prevention and treatment: According to the New York Times, researchers reported that a single shot for HIV administered every two months has proved to be more effective than a daily pill at preventing HIV in women.

    November 12, 2020
    General, PrEP
    Well and Good

  • HIV/AIDS Stigma Drops by 80 Percent in Rwanda: Survey

    Stigma and discrimination against people infected with HIV/AIDS in Rwanda has dropped by 80 percent over recent years, showed a survey Tuesday. "Scaling up awareness campaigns, healthcare and universal access to antiretroviral drugs for people living with HIV/AIDS was responsible for reducing stigma," Innocent Turate, head of HIV and disease prevention control department at the Rwanda Biomedical Center (RBC) said at a virtual event when the survey was released.

    November 11, 2020
    General
    Xinhua

  • Opinion: Why Mental Health Integration in HIV and TB Programs Is a Win-Win

    This week, the board of the Global Fund to Fight AIDS, Tuberculosis and Malaria meets to discuss the fund’s strategy for the years to come. This is a unique opportunity to ensure that mental health—a missing piece in current strategies—becomes an integral part of the global responses to HIV and TB—from prevention, to testing, to treatment and care, and addressing stigma related to mental health, HIV, and TB.

    November 11, 2020
    General
    Devex

  • European HIV Doctors Conduct Their First-Ever Region-Wide Audit of Services

    For the first time, the European AIDS Clinical Society (EACS) and the European Centre for Disease Prevention and Control (ECDC) have conducted an audit of one aspect of HIV clinical services, measuring provision in five disparate countries against one set of standards and comparing the degree to which different countries and clinics meet that standard. The screening, prevention and management of viral hepatitis in people with HIV was audited in Georgia, Germany, Poland, Romania and Spain.

    November 11, 2020
    General
    aidsmap

  • For PrEP to Work, Shared Doctor-Patient Decision-Making Is Key

    HIV-negative people currently have two options when it comes to pre-exposure prophylaxis (PrEP): oral emtricitabine/tenofovir disoproxil fumarate (a.k.a. FTC/TDF, or Truvada) and a newer alternative, oral emtricitabine/tenofovir alafenamide (F/TAF, Descovy). The process of choosing between these two options—or of potentially switching from one to the other—is often not straightforward, and the messaging a patient receives on these drugs (and on potential dosing schedules) can muddy the waters. What’s the best way to ensure a patient ends up with the most successful option?

    November 10, 2020
    PrEP
    The BodyPro

  • Shot to Prevent HIV Works Better Than Daily Pill in Women

    A single shot given every two months has proved to be more effective than a daily pill at preventing HIV in women, researchers reported on Monday, an advance that medical experts hailed as groundbreaking in the fight against the deadly virus that causes AIDS.

    November 9, 2020
    PrEP
    New York Times

  • Study Finds Long-Acting Shot Helps Women Avoid HIV Infection

    Researchers are stopping a study early after finding that a shot of an experimental medicine every two months worked better than daily pills to help keep women from catching HIV from an infected sex partner.

    November 9, 2020
    PrEP
    Washington Post

  • US Homeless Shelters Are Key Centers for HIV and Tuberculosis Prevention, Experts Say

    HIV and tuberculosis (TB) often go hand in hand among people experiencing homelessness (PEH) in the US—a reality that gives public health officials an opportunity to utilize shelters in tackling both viruses at the same time, new research suggests.

    November 9, 2020
    General
    The BodyPro

  • “In My Heart I Scream”: Involve Young People in Decision-Making About Their Lives

    “As a young woman leader, I always remember my 16-year-old self as a girl who needed access to a range of HIV-prevention commodities, but there were only male condoms available, and in very rare cases, pre-exposure prophylaxis.” So says Nyasha Phanisa Sithole, an HIV, sexual and reproductive health and rights and gender activist from Zimbabwe.

    November 8, 2020
    Male and Female Condoms, PrEP
    Mail & Guardian

  • KEMRI HIV Cure Studies Paused as World Focuses on COVID-19

    The Kenya Medical Research Institute was one of the institutions that was poised to host some HIV Cure studies but with the onset of COVID-19, the international partners who sponsored the studies paused the implementation as the world focuses on COVID-19 pandemic.

    November 8, 2020
    Cure
    The Star

Published Research

Announcements